I read the transcripts, I think this was a very good C.C. I see a turn around coming. I would like to have heard some details on the Astrazeneca lawsuit! I don't believe they will be a threat. EPANOVA numbers for non lipid parameters are not as good as Vascepa. The trial itself as posted on IHUB was questionable. The patent lawsuit, can certainly throw a wrench into Astrazenecas plans, if they loose.
News 
Market Data 
Discover 
AI
